MindBio begins patient enrolment in advanced stage cancer therapy trial

MindBio Therapeutics has started enrolling patients in its Phase II trial evaluating microdoses of lysergic acid diethylamide (LSD) combined with meaning-centred psychotherapy in advanced-stage cancer patients experiencing emotional distress.